A
Aerovate Therapeutics D
D
AVTE
2.65000
USD
-0.04
(-1.49%)
Market Closed
Volume
3,765
EPS
-2
Div Yield
-
P/E
-1
Market Cap
76,517,459
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Aerovate Therapeutics
Sector: Healthcare
Industry: Biotechnology
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powderinhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.